CA3176584A1 - Silver salt-containing ophthalmic aqueous composition filled in resin container - Google Patents

Silver salt-containing ophthalmic aqueous composition filled in resin container

Info

Publication number
CA3176584A1
CA3176584A1 CA3176584A CA3176584A CA3176584A1 CA 3176584 A1 CA3176584 A1 CA 3176584A1 CA 3176584 A CA3176584 A CA 3176584A CA 3176584 A CA3176584 A CA 3176584A CA 3176584 A1 CA3176584 A1 CA 3176584A1
Authority
CA
Canada
Prior art keywords
aqueous composition
ophthalmic aqueous
ophthalmic
present
based resin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3176584A
Other languages
English (en)
French (fr)
Inventor
Yusuke MOMOKAWA
Maki IIDA
Hiroyuki Asada
Toyomi FUJISAWA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of CA3176584A1 publication Critical patent/CA3176584A1/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/1468Containers characterised by specific material properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/47042-Quinolinones, e.g. carbostyril
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Bridges Or Land Bridges (AREA)
CA3176584A 2020-03-31 2021-02-26 Silver salt-containing ophthalmic aqueous composition filled in resin container Pending CA3176584A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020-062252 2020-03-31
JP2020062252 2020-03-31
PCT/JP2021/007366 WO2021199814A1 (ja) 2020-03-31 2021-02-26 樹脂製容器に充填された銀塩含有眼科用水性組成物

Publications (1)

Publication Number Publication Date
CA3176584A1 true CA3176584A1 (en) 2021-10-07

Family

ID=77930318

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3176584A Pending CA3176584A1 (en) 2020-03-31 2021-02-26 Silver salt-containing ophthalmic aqueous composition filled in resin container

Country Status (8)

Country Link
US (1) US20230145529A1 (enExample)
EP (1) EP4129341A4 (enExample)
JP (4) JP7053966B2 (enExample)
KR (2) KR102705675B1 (enExample)
CN (1) CN115348871B (enExample)
CA (1) CA3176584A1 (enExample)
TW (1) TWI896607B (enExample)
WO (1) WO2021199814A1 (enExample)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
JP4683835B2 (ja) * 2003-12-01 2011-05-18 ロート製薬株式会社 防腐剤及びこれを含有する水性組成物
KR100557679B1 (ko) * 2004-01-07 2006-03-07 뉴바이오 (주) 4차암모늄의 공중합에 의한 콘택트렌즈제조방법
JP4856392B2 (ja) 2004-04-23 2012-01-18 ロート製薬株式会社 防腐剤及びこれを含有する水性組成物
JP2006162648A (ja) 2004-12-02 2006-06-22 Konica Minolta Business Technologies Inc 現像装置及び画像形成装置
BRPI0818459A2 (pt) * 2007-10-16 2015-04-14 Sun Pharma Advanced Res Co Ltd Composição farmacêutica adequada para uso oftálmico.
IN2014MN01555A (enExample) * 2012-02-27 2015-07-03 Rohto Pharma
KR20150119303A (ko) * 2013-02-15 2015-10-23 센주 세이야꾸 가부시키가이샤 항균성 금속을 함유하는 디플루프레드네이트 유액 조성물
US20160022648A1 (en) * 2013-03-13 2016-01-28 Santen Pharmaceutical Co., Ltd. Therapeutic agent for meibomian gland dysfunction
SG11201705138QA (en) * 2014-12-25 2017-07-28 Santen Pharmaceutical Co Ltd Aqueous ophthalmic solution
JP6611444B2 (ja) * 2015-03-24 2019-11-27 ロート製薬株式会社 眼科用組成物
TWI711453B (zh) 2015-06-05 2020-12-01 日商參天製藥股份有限公司 抑制水性點眼液中之洛赫西定類的殘存率降低之方法
JP6615548B2 (ja) * 2015-08-06 2019-12-04 ロート製薬株式会社 眼科組成物
JP7317714B2 (ja) * 2017-12-01 2023-07-31 参天製薬株式会社 眼科用製品
US11602561B2 (en) * 2018-06-28 2023-03-14 Csp Advanced Solutions Inc. Treatment method and system for epidemic keratoconjunctivitis
JP7139206B2 (ja) 2018-09-21 2022-09-20 小林製薬株式会社 医薬組成物

Also Published As

Publication number Publication date
CN115348871A (zh) 2022-11-15
JP2025146955A (ja) 2025-10-03
US20230145529A1 (en) 2023-05-11
KR20220161379A (ko) 2022-12-06
WO2021199814A1 (ja) 2021-10-07
JP7169477B2 (ja) 2022-11-10
JP2023001184A (ja) 2023-01-04
JPWO2021199814A1 (enExample) 2021-10-07
JP2022087168A (ja) 2022-06-09
EP4129341A4 (en) 2024-04-24
JP7053966B2 (ja) 2022-04-12
JP7721498B2 (ja) 2025-08-12
KR102705675B1 (ko) 2024-09-11
EP4129341A1 (en) 2023-02-08
CN115348871B (zh) 2025-08-08
KR20240135080A (ko) 2024-09-10
TW202203920A (zh) 2022-02-01
TWI896607B (zh) 2025-09-11

Similar Documents

Publication Publication Date Title
JP6903448B2 (ja) ドルゾラミドとブリモニジンを含む医薬組成物
KR102075173B1 (ko) 보존 효력을 갖는 브롬페낙 수성 액제 조성물
JP2023093601A (ja) 眼科用製品
CA3176584A1 (en) Silver salt-containing ophthalmic aqueous composition filled in resin container
JP6702754B2 (ja) ドルゾラミドを含有する防腐剤
US8785497B2 (en) Aqueous ophthalmic compositions containing anionic therapeutic agents
US11324829B2 (en) Antiseptic agent comprising meglumine or salt thereof
JP6877613B2 (ja) 防腐効果のある医薬の組合せ
JP4892291B2 (ja) 眼科用防腐組成物
JP2023155169A (ja) 眼科用水性組成物
WO2023204297A1 (ja) セペタプロストを含有する眼科用組成物
JP2022180452A (ja) レバミピドまたはその塩および高分子を含有する水性懸濁液